ESC 365 - Comparison of three different platelet function tests in patients on P2Y12 inhibitors in correlation to genetic background.

ESC Premium Access

Comparison of three different platelet function tests in patients on P2Y12 inhibitors in correlation to genetic background.

Session: Poster Session 6 - Pharmacogenetics - New sights on the horizon

Topic: Pharmacogenetics

Speaker: Mrs R. Olie (Maastricht, NL)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Mrs Renske Olie

Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))

0 follower

5 more presentations in this session

HDL-cholesterol dysfunction and inflammation in patients with genotypes associated with different responses to dalcetrapib

Speaker: Doctor A. Franci (Sao Paulo, BR)

Association of CYP2C19*2 and PEAR1 gene variant with platelet reactivity and clinical outcomes in patients undergoing stenting and treated with aspirin and clopidogrel

Speaker: Doctor K. Xu (Shanghai, CN)

CYP2C19 genotyping as complementary tool for guidance of early de-escalation of antiplatelet treatment in acute coronary syndrome patients

Speaker: Doctor L. Gross (Munich, DE)

Prasugrel or clopidogrel in non-st-elevation acute coronary syndrome with CYP2C19 genetic variants undergoing percutaneous coronary intervention

Speaker: Doctor S. Kim (Busan, KR)

Genetic influence on warfarin dose determination

Speaker: Doctor J. Li (Busan, KR)

Access the full session

Poster Session 6 - Pharmacogenetics - New sights on the horizon

Speakers: Mrs R. Olie, Doctor A. Franci, Doctor K. Xu, Doctor L. Gross, Doctor S. Kim...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources